Department of Neurology, Tsuchiura Kyodo General Hospital, 4-1-1Otsuno, Tsuchiura-shi, Ibaraki, 300-0028, Japan.
BMC Infect Dis. 2018 Jul 6;18(1):313. doi: 10.1186/s12879-018-3229-z.
Although paradoxical reactions (PRs) to anti-tuberculosis (anti-TB) therapy during treatment are well-established occurrences, PRs presenting as a new lesion after the completion of treatment are extremely rare, and little is known about the management of such cases, particularly of central nervous system (CNS) tuberculosis.
A 27-year-old female, with a past medical history of tuberculous meningitis 10 years ago and who completed the anti-TB treatment with asymptomatic remnant tuberculomas in the basal cistern, was admitted to our hospital because of a headache and the worsening of pre-existing visual disturbance. Contrast-enhanced T1-weighted brain magnetic resonance imaging (MRI) revealed new tuberculomas in the left sylvian fissure with a diffuse low signal around it. Because repeated polymerase chain reaction and Mycobacterium tuberculosis culture presented negative results and the patient had no laboratory data suggestive of a relapse of tuberculous meningitis, she was diagnosed with late-onset post-treatment PRs and treated with oral corticosteroids, tapered off over 1 year. Eventually, the symptoms were relieved, and the tuberculomas disappeared.
Clinicians should consider the possibility of PRs long after the completion of tuberculous meningitis treatment. Hence, a precise MRI-based examination is imperative for the follow-up of CNS tuberculosis, and the unnecessary administration of anti-TB drugs should be avoided. The use of corticosteroids as a treatment option for post-treatment PRs is seemingly safe when the isolated M. tuberculosis is sensitive to the first-line anti-TB therapy.
尽管抗结核(anti-TB)治疗期间出现矛盾反应(PRs)是已确立的现象,但治疗完成后出现新病灶的 PR 极为罕见,对于此类病例的处理知之甚少,尤其是中枢神经系统(CNS)结核。
一名 27 岁女性,10 年前患有结核性脑膜炎病史,在基底池遗留无症状结核瘤的情况下完成了抗结核治疗,因头痛和原有视力障碍恶化而被收入我院。增强 T1 加权脑磁共振成像(MRI)显示左侧外侧裂有新的结核瘤,周围有弥漫性低信号。由于重复聚合酶链反应和结核分枝杆菌培养均呈阴性结果,且患者无实验室数据提示结核性脑膜炎复发,因此诊断为迟发性治疗后 PRs,并给予口服皮质类固醇治疗,1 年内逐渐减量。最终,症状缓解,结核瘤消失。
临床医生应考虑结核性脑膜炎治疗完成后很长时间出现 PRs 的可能性。因此,对于 CNS 结核的随访,精确的基于 MRI 的检查至关重要,应避免不必要的抗结核药物治疗。对于孤立的结核分枝杆菌对一线抗结核治疗敏感的患者,皮质类固醇作为治疗治疗后 PRs 的选择似乎是安全的。